Key Takeaways
- The validation paradigm built for predictive AI doesn’t work for AI that reasons through multiple steps. Predictive models have a fixed output to evaluate. A multi-step reasoning pipeline makes sequential decisions, and each one shapes everything that follows.
- The failure mode isn’t inaccuracy; it’s invisible inaccuracy. When a reasoning chain embeds flawed assumptions at an early decision point, the output looks credible while the error propagates forward silently.
- The field needs a new unit of analysis. Validating this kind of RWE means auditing the reasoning chain, not just measuring the result.
Historically, validating an AI tool for healthcare research followed an established process: train your model, run a test set, and then assess performance. If the area under the curve (AUC) was high enough, the model was greenlit. This traditional approach works well for predictive analytics, where the task is well-defined, outputs are discrete, and success is measurable against a known answer.
That same logic doesn’t apply to RWE systems built to reason through a problem rather than simply predict an outcome.
The Architecture Has Changed
Predictive models are static: they encode a relationship during training and apply it uniformly at inference. The pipeline is short, and the decision space is bounded. Validation asks one question: Does the model’s prediction hold up on new data?
A reasoning-based RWE pipeline works differently. It doesn’t predict. It reasons sequentially and autonomously through a chain of methodological decisions: defining the patient cohort, specifying the exposure window, handling missing data, estimating a causal effect, and aligning the design with the regulatory context. Each decision embeds assumptions. Each assumption shapes the ones that follow.
When a researcher conducts an observational study manually, every methodological choice is explicit. There’s a documented protocol that’s defensible in peer review. When an AI system runs the same study, those choices still happen, but faster, and often with less of a paper trail behind them. This makes retrospective review nearly impossible.
The dangerous part is that these solutions often provide the wrong answer while producing an output that looks entirely reasonable.
Where the Errors Actually Enter
The most vulnerable points in these pipelines aren’t where one would assume.
Cohort selection is the first and highest-stakes decision point. Who gets included, on what basis, and with what exclusion logic shapes every downstream estimate. A cohort selection algorithm that systematically misses a patient subpopulation, or that handles enrollment gaps differently than a human researcher would, produces a result that is internally consistent and externally indefensible. And the output carries no flag that it happened.
Consider a line-of-therapy analysis, for example. Defining when a patient moves from first-line to second-line therapy sounds like a simple data lookup, but it’s actually a cohort-defining decision. A gap in prescription fills, a new diagnosis code, or a switch in NDC can each trigger a different line assignment, and the pipeline makes that call autonomously for every patient at scale. If the underlying logic is off, the output still looks complete. It’s just wrong, and there’s no visible seam where the error entered.
Missing data handling is where assumptions compound silently: the choice between imputation strategies, the decision to exclude patients with incomplete follow-up, and the treatment of patients who left the dataset because they switched payers. Each of these is its own methodological decision with real downstream consequences. That payer-switch scenario is the same edge case that came up in the first piece in this series. But the question here isn’t whether the model can see that the patient left. It’s what the pipeline does next: impute, exclude, or flag. Traditional output validation wasn’t built to surface any of this, so it stays invisible by default.
Causal inference logic is where the deepest gap lies. AI systems are exceptionally good at finding associations in large datasets. The separate skill of causal reasoning is not something these systems have by default. In predictive analytics, that distinction doesn’t matter much. In RWE, it matters enormously. A confounded association, presented as a treatment effect in a regulatory dossier, is a fundamental credibility failure.
What Validation Actually Requires
If the validation object for predictive models is the output, the validation object for this kind of RWE must be the reasoning chain itself: the full sequence of decisions connecting a research question to an evidence claim. In practice, that points to three things the field has yet to standardize:
- Decision-level traceability. Rather than “here is the result and here is how it was computed,” what’s needed is closer to “here’s the cohort selection logic, these were the exclusions, and here’s how sensitive the result is to alternative definitions.” Every decision point must be auditable, not just the final calculation.
- Assumption documentation as a first-class output. The hidden stack of analytic choices about what was excluded, imputed, and assumed complete needs to be surfaced explicitly, in terms that an independent reviewer can evaluate. Regulators and payers shouldn’t have to reverse-engineer what the pipeline assumed along the way.
- Causal model specification, not just causal claims. When the pipeline estimates a treatment effect, it must be possible to identify the causal model underlying it: which confounders were addressed, which instrumental variables were used, and how time-varying factors were accounted for. Causal inference is a design requirement that must be explicitly built in and validated.
None of this is beyond what the field can do. It is, however, beyond what current output validation frameworks were designed to deliver. The question for HEOR teams building AI into their evidence workflows is whether they are applying a predictive validation paradigm to a system that operates by a fundamentally different logic.
The reckoning this column opened with, the one coming for AI-generated RWE that skipped credibility as a design principle, will arrive fastest for organizations that never asked that question.
Built for the Reasoning Chain
Komodo Health built Marmot™ around the failure points that make this kind of RWE vulnerable: undocumented assumptions, invisible decision logic, and unverified causal inference. Marmot’s architecture treats every decision point in the evidence pipeline as a discrete, auditable node. Cohort selection logic, missing data handling, and causal model specification are explicit, logged, and reproducible.
In that same line-of-therapy example, Marmot logs the exact rule it used to assign each treatment line, so a reviewer can see why a patient was counted as second-line rather than first, not just the final count. That same visibility carries through the rest of the pipeline. Every output includes an audit trail of the validation checks and independent verification against the clinical coding standards behind it. The HEOR team owns the study design. Marmot executes it precisely and reproduces the same result months later.
The standard for this kind of RWE is not accuracy alone. It’s traceable, defensible reasoning, from research question to evidence claim, at every step along the way.
Grounded. Explainable. Reproducible. Verified. Governed. This piece is part of The RWE Standard, Komodo’s column on HEOR and real-world evidence in the age of AI. Read part 1 here
